Clinical trial
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in…
NCT00462397 · University College London Hospitals, Other · Unknown status
Key facts
| NCT number | NCT00462397 |
|---|---|
| Title | Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer |
| Official title | Phase II Study of Weekly Neoadjuvant Chemotherapy Followed by Radical Chemoradiation for Locally Advanced Cervical Cancer |
| Lead sponsor | University College London Hospitals, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carboplatin, cisplatin, paclitaxel, neoadjuvant therapy, brachytherapy, radiation therapy |
| Enrollment | 50 |
| Start date | Jun 1, 2005 |
| First posted | Apr 19, 2007 |
| Last update posted | Aug 26, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: